Could home blood tests transform hemophilia care? study seeks patient views
NCT ID NCT06702579
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how patients with hemophilia A or those on blood thinners feel about monitoring their blood clotting at home. Researchers interviewed 19 people to understand their needs and hopes for a new device that could measure clotting factors. The goal was to gather insights to guide future home monitoring tools, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help design home monitoring devices that make hemophilia care easier and give patients more independence.
- What could go wrong
- This is a small, terminated observational study with only 19 participants, so findings may not apply broadly. No treatment is being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTICOAGULANT THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radboudumc
Nijmegen, Gelderland, 6525GA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny chest patch could tell doctors who's ready to leave the hospital
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Can a new clotting factor offer better bleed protection for severe hemophilia?
- Do newer hemophilia drugs protect joints better? study aims to find out
- Radar could replace wires: contactless Vital-Sign monitoring tested
- Newborn screening study aims to catch rare diseases at birth